Search for an orphan drug
Other search option(s)
GLIVEC
Imatinib mesilateMarketing authorisation without orphan designation - Europe
- Diseases list
- Chronic myeloid leukemia
- Acute lymphoblastic leukemia
- Chronic eosinophilic leukemia
- Gastrointestinal stromal tumor
- Dermatofibrosarcoma protuberans
- Idiopathic hypereosinophilic syndrome
- Myelodysplastic/myeloproliferative disease
- Detailed information
Marketing authorisation with orphan designation - Japan
- Diseases list
- Chronic myeloid leukemia
- Gastrointestinal stromal tumor
- Detailed information
Marketing authorisation with orphan designation - Australia
- Diseases list
- Systemic mastocytosis
- Chronic myeloid leukemia
- Acute lymphoblastic leukemia
- Gastrointestinal stromal tumor
- Dermatofibrosarcoma protuberans
- Idiopathic hypereosinophilic syndrome
- Detailed information
Additional information
Research on this medical product
Appraisal/reimbursement
The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.